15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces Addition of COVI-STIX™ (Covid-19 Virus Rapid Antigen Detection Test) to the Official Mexican Government List of Emergency Use Approved Point of Care Rapid Antigen Tests
02. Juni 2021 07:00 ET | Sorrento Therapeutics, Inc.
COVI-STIX has been added to the official government list of point of care rapid antigen tests useful for the detection of SARS-CoV-2 in Mexico...